Insurance by BogdanovaThe Encyclopedia of Insurance and Risk Science

RESEARCH DOSSIER

Broker Quotation Panel Design and Quote Allocation Fairness

Abstract. Broker quotation panels are institutional arrangements through which insurance intermediaries define the set of insurers available to serve customers and distribute individual requests for insurance among eligible providers. Their scientific significance arises from the intersection of search economics, underwriting heterogeneity, intermediary agency, competition, contractual suitability, and the distribution of opportunities to obtain protection. This monograph examines panel admission and removal, the differentiation of nominal and effective market coverage, quote-request routing, sequential and simultaneous search, remuneration-induced steering, genuine bidding, the comparability and presentation of returned offers, and the evaluation of customer and insurer outcomes. It compares selected European Union and United Kingdom rules with New York compensation-disclosure practice and Ontario supervisory guidance, while distinguishing enforceable requirements from guidance and historical enforcement evidence. An analytical decomposition of the quotation pathway, a reproducible hypothetical example, and a specification for matched quote audits establish the evidence needed to distinguish legitimate risk-based selection from preferential routing. The principal conclusion is that defensible panel governance must demonstrate the relevance of available alternatives, the integrity of each transition from eligibility to recommendation, and the adequacy of the resulting insurance choices. The research is a documentary and methodological synthesis; it does not estimate market-wide discrimination or claim a new theory.

Keywords: Insurance brokerage; insurer quotation panels; quote allocation; insurance distribution; fair personal analysis; search frictions; intermediary compensation; referral steering; market coverage; insurance access; risk classification; competition; matched audits; outcome monitoring; algorithmic accountability.

Introduction

Insurance intermediation organizes the encounter between a heterogeneous population of risks and an equally heterogeneous supply of contractual protection. A broker gathers information, identifies possible insurers, translates risk characteristics into an underwriting submission, elicits terms, compares alternatives, and assists the customer in deciding whether to conclude a contract. The quotation panel is the institutional infrastructure through which much of this work is performed. It determines which suppliers can be approached, under which conditions, and with what degree of effort. An apparently simple customer-facing list of prices is therefore the end of a chain of decisions about market access.

The research object is the design of the panel and the allocation of customer requests at the quotation stage, across retail and ordinary commercial insurance. Its unit of observation is a customer insurance inquiry for a particular product, exposure, jurisdiction, and effective date, together with the contemporaneous set of potentially relevant insurers and the actual sequence of intermediary actions. Enterprise-scale syndication, layered capacity procurement and bespoke placement tenders are adjacent subjects. They enter this inquiry only where they illuminate the integrity of quote allocation. The separate subject of comparison-site ranking concerns the presentation and positioning of products on digital platforms; here, presentation is studied insofar as it follows an intermediary's selection and solicitation of insurers.

The central problem is informational. A broker can accurately describe a price as the lowest received while failing to establish that the solicitation process considered appropriate alternatives. The customer may observe neither excluded insurers nor suppressed quotes. An insurer may be unaware that an eligible submission was withheld. Supervisors may receive counts of issued policies without records of requests never sent. A scientifically credible assessment therefore requires evidence of the opportunity set and the decisions shaping it, not merely an examination of completed sales.

The inquiry combines institutional economics, comparative documentary law, analysis of supervisory publications, and a methodological treatment of matched observations. It distinguishes facts established by legal texts from institutional interpretations, findings of previous studies from its own analytical deductions, and illustrative numbers from observed data. The selection of jurisdictions is purposeful: the EU and UK supply explicit rules and guidance on fair analysis; New York supplies a historically important record of incentive conflicts and producer disclosure; Ontario illustrates supervisory adoption of lifecycle fair-treatment principles. These examples do not constitute a census of international law. The original text of the EU Insurance Distribution Directive was examined for its pertinent provisions; the 2024 consolidated document was identified but did not render in the research environment. Country-specific implementing provisions and later amendments must be checked when applying the analysis to an individual transaction.

Academic publications for which full text was unavailable are used only for conclusions apparent in the accessible abstracts and verified bibliographic records. No independent broker-level data were supplied. The numerical examples are transparent hypothetical constructions, and empirical designs specify the data that would be needed to evaluate real conduct. The scientific contribution is the reconciliation of previously established economic and regulatory insights with the concrete chronology and measurement problems of intermediary quotation. It makes no claim of priority for the underlying economic or statistical concepts.

Insurance Quotation Panels as Matching Institutions

The intermediary and the feasible contract set

Insurance differs from the purchase of a standardized physical good because the price, availability, and promised performance of the contract depend jointly on the customer, the risk, the insurer, and the contract's wording. An insurer may offer a policy in one territory but decline another; it may accept a class of property subject to a retention, a protective safeguard, or an aggregate exposure limit. A broker who can accurately identify underwriting appetites saves both the customer and insurer time. Intermediation creates value when information collected once can be translated into submissions to multiple suitable providers.

Cummins and Doherty (2006), in The Economics of Insurance Intermediaries, characterize independent intermediaries in commercial property-casualty markets as institutions matching insurance needs to insurer capabilities. Their published abstract also discusses information asymmetry, compensation and bidding. This supplies an economic starting point for understanding why a broker's relationships can improve rather than simply restrict competition. Expertise about unusual exposure characteristics, a reliable submission process and knowledge of contractual differences can make a narrower group of potential markets more productive than indiscriminate solicitation.

A quotation panel is the maintained collection of insurers or underwriting markets that an intermediary is operationally and contractually prepared to approach for specified classes of business. Panel membership may involve agency agreements, access to wholesale intermediaries, underwriting portals, technical integrations, service-level agreements or arrangements for submitting risks requiring manual assessment. Its design is a relatively durable institutional decision. Quote routing is the transaction-specific decision about which of these markets actually receives the request, at what time, and with which information.

It is essential to distinguish the legal insurer from its retail brand, distribution endpoint, managing general agent and underwriting capacity provider. Two quote engines may expose different products backed by the same insurer. Two competing insurers within an ownership group may offer genuinely distinct coverage terms while remaining economically affiliated. Breadth should therefore be recorded at multiple levels: product, underwriting entity, distribution endpoint and ultimate group. Counting names alone can mistake branding diversity for independent underwriting alternatives.

A useful conceptual sequence begins with the relevant market of legally available suppliers, passes through the intermediary's admitted panel and the risk-specific eligible subset, and ends with requests, responses, disclosed offers, recommendations and acceptances. Each successive stage ordinarily restricts the number of alternatives, although an intermediary can widen the search by using an authorized referral or obtaining access to a previously omitted market. This sequence is descriptive. It does not establish that every reduction is harmful or that every retained alternative is suitable.

Heterogeneity in insurance demands and needs

Consider two homeowners with the same insured value. One owns a conventional property in a region with ample capacity. The other owns a property with a nonstandard construction method, located in a flood-prone area. A general home panel with ten insurers might quote competitively for the first customer, while only two members can consider the second. If the broker has access to specialist markets, effective service for the second customer may require a different referral path altogether. Equal treatment of the two inquiries does not mean identical routing. It means that differences in routing can be justified in relation to their relevant insurance circumstances and that the second inquiry is not prematurely abandoned because serving it is less profitable.

The customer-specific feasible set is broader than an insurer's initial appetite flag and narrower than the population of all licensed insurers. It includes constraints on territory, capacity, policy period, product scope, applicant characteristics, distribution authorization and the customer's requirements. Some constraints are observable before a request is sent; others are revealed only through underwriting. The audit must retain this distinction. A predicted rejection is a model-based assessment of an uncertain outcome, whereas an actual decline is evidence of a decision made by the insurer.

Eligibility also depends on the purpose of the comparison. A customer may need a minimum liability limit to satisfy a commercial contract, loss of use coverage, a particular insured peril, or a deductible no greater than its available liquidity. An inexpensive product that fails these conditions is not a feasible substitute. A materially more expensive product with superior coverage may be the appropriate recommendation. Quote count, premium minimization and coverage adequacy are related but distinct measures.

The economic choice includes costs borne by both sides of the intermediary relationship. A poorly prepared submission can induce additional requests for information, inconsistent terms and conservative pricing. An intermediary who improves data quality may increase response probability and reduce duplication. But the same intermediary can exploit the customer’s limited ability to observe the completeness of search. Focht, Richter and Schiller (2013) examine this relationship in their research on intermediation and matching. Their accessible abstract distinguishes honest matching from strategic conduct and discusses how alternative remuneration arrangements interact with those conditions. The implication for panel design is analytical: governance must assess the actual intermediary behavior as well as its nominal business model.

The two-sided nature of access

The panel functions as an intermediary-controlled interface between customer demand and insurance supply. From the buyer's perspective, fair access concerns a reasonable opportunity to obtain relevant, intelligible and genuinely available offers. From the insurer's perspective, it concerns access to eligible requests under objective contractual and business criteria. These two forms of fairness may coincide when wider effective competition improves the customer's terms. They can also diverge. An entrant with limited claims capacity or a poorly suited product need not receive the same volume as a more capable insurer.

Equal market shares are not an intrinsic requirement of fair quote allocation. An insurer that specializes in a class of risk may justifiably receive a disproportionate number of submissions within that class. Conversely, concentrated allocations may be evidence of steering if they cannot be explained by relevant differences in customer need, appetite, price, coverage, service or capacity. The relevant benchmark is conditional opportunity, not uniform allocation.

The intermediary's legal role is consequential. An agent committed to a particular insurer, a broker representing a customer, and a comparison intermediary providing limited information can have different authorizations and duties. The scientific assessment must establish which service was promised, how the relationship was represented, and what obligations apply before asking whether actual search was sufficient. An exclusive arrangement honestly identified to customers raises different issues from a claim of independent or comprehensive analysis supported by a heavily restricted panel.

Roles may change across stages of a transaction, especially where several intermediaries participate. A retail broker may gather demands and needs, a wholesale intermediary may identify specialist capacity, and an insurer or delegated underwriter may determine acceptance. Every actor's decision and remuneration should remain distinguishable. Otherwise the broker can attribute its own routing restrictions to underwriting appetite, or a downstream constraint can be incorrectly recorded as an upstream omission.

Panel Admission, Exclusions and Market Coverage

Admission criteria and the maintenance of the panel

The admission decision has long-term effects because it determines the set of options available to the subsequent allocation mechanism. Appropriate criteria include authorization to transact, underwriting appetite, financial and operational reliability, product quality, claims capability, technical compatibility, service performance, data-security requirements and relevant pricing characteristics. Their significance varies by product. The broker should document the connection between each criterion and the provision of suitable insurance service. A new carrier may be admitted on a limited basis while its performance and underwriting fit are assessed.

The most direct regulatory example is the UK Financial Conduct Authority's ICOBS panel guidance, in ICOBS 4.1.8G. This guidance recognizes a regularly reviewed panel as a possible means of providing advice based on fair analysis. It connects selection criteria to the product and service offered to customers, rather than allowing the firm's own benefit to be the sole basis. It also draws attention to changes in price and product features. The guidance describes an approach to satisfying fair-analysis obligations; it does not establish that the existence of any panel is by itself sufficient.

A complete admission file identifies the relevant product territory and risk classes, the decision maker, the versions of the insurer's appetite criteria, the evaluated features, the corporate group, contract and remuneration arrangements, access restrictions, and the reason for admission or rejection. The decision to remove an insurer requires equivalent documentation. An apparent fall in quote performance could reflect an obsolete technical integration, a temporary capacity restriction, a change in the customers being submitted, or actual deterioration of insurer service. The investigation should distinguish those causes before imposing a durable exclusion.

Technical capability can create a particularly important barrier. A broker may favor insurers that offer rapid machine-readable quotes over an insurer requiring a manual submission. Automation reduces processing cost, and that efficiency can benefit the buyer. Yet an asynchronous route can be economically appropriate for customers with complex needs. A panel composed entirely of instant-response insurers may offer poor access to risks outside standardized underwriting categories. Technical cost should be evaluated explicitly against the importance of the omitted insurance alternatives.

A panel review needs both scheduled and event-driven elements. Scheduled reviews identify changes in breadth, product quality and concentration; event-driven reviews address material changes such as a new entrant, revised eligibility, insurer withdrawal, severe service deterioration or a new compensation arrangement. The cadence should follow the volatility and complexity of each product market. A review that merely renews existing contractual relationships is not an assessment of market relevance.

Nominal breadth and effective breadth

Define M(i,t) as the reference set of potentially relevant insurer-product alternatives for inquiry i at time t, under a consistent definition of the market. Define P(i,t) as the part of that set accessible through the broker's panel, and E(i,t) as the panel alternatives that appear eligible given contemporaneous information. The quantity |P|/|M| is nominal reference-set coverage. An eligibility-weighted measure can instead compare the available alternatives with the estimated or verified eligible reference set. Where the market denominator is incompletely observed, the broker must describe the reference-set construction and avoid presenting an estimate as exhaustive coverage.

A count-based measure assigns equal weight to every insurer-product alternative. A weighted measure can reflect the relevance of product features, segment-specific capacity or the importance of a coverage distinction. Such weights require a stated basis and sensitivity checks; they must not simply reproduce the broker's current sales shares. A high historical share may be the product of previous steering and therefore an inappropriate measure of customer relevance. Market-wide premium share can describe concentration, but it is not automatically the correct weight for an individual risk.

Availability also differs from independent competition. If six brands quote through the same group, the effective number of independently controlled alternatives is smaller than the nominal brand count. A concentration measure can be calculated as the sum of squared group shares across the chosen denominator. Shares can refer to eligible alternatives, requests sent, valid responses, or policies bound. The denominator must be stated each time. A concentration measure calculated from bound business cannot, on its own, establish concentration in the opportunity to quote.

EIOPA's 2026 distribution market structure overview reports that registered intermediary numbers in the EU declined by 7.5 percent from 2020 to 2024 and warns that national registration and data-collection practices differ. These aggregates provide context for channels of distribution and consolidation. They do not identify how individual brokers construct their panels or establish whether consolidation caused unfair allocation. The distinction illustrates why aggregate structure and transaction-level conduct require different evidence.

The appropriate comparator may include direct writers with whom the broker cannot transact. Such firms matter when the broker claims to cover the wider market. They can be recorded as relevant but inaccessible alternatives, with the limitation communicated accurately to the customer. It is methodologically unsound to remove them from the reference universe merely because they do not belong to the panel. Conversely, including all licensed insurers regardless of product or territory creates an artificial coverage deficit. Two denominators are often informative: the relevant external reference market and the reachable panel subset. The difference between them describes a limitation in service reach.

Exclusion, specialization and access for marginal risks

A specialist panel can rationally exclude markets that cannot deliver the required insurance. Specialization creates efficiency through expertise and compatibility. However, exclusion criteria should be evaluated for their effects on the population they serve. A broker with substantial household or small-business traffic may identify a growing segment of underserved inquiries for which its present distribution agreements produce repeated no-quote outcomes. The response might be to add a specialist insurer, establish an appropriate referral, improve application support or correct inaccurate appetite information.

The panel must distinguish an insurer that is inaccessible because no agreement exists from an insurer that is available but not selected, one that declines the submission, and one that quotes unattractive terms. These categories have different remedies. An access agreement may address the first; revised allocation rules the second; better or more complete risk information the third; and broader search or different contract design the fourth. Lumping them together as a decline deprives the broker of information about avoidable barriers.

A prudent review considers both breadth and depth. Breadth refers to the variety of meaningful alternatives within the relevant risk universe. Depth refers to the number of genuine competitors for individual inquiries. A panel with five specialist insurers covering entirely disjoint classes can have substantial breadth at portfolio level while providing little competition within each segment. A panel of five near-identical providers may offer depth for routine risks but very narrow breadth for customers with unusual needs. The adequacy of the panel is thus a question about distributions of opportunities across inquiries, not a single total.

Compensation arrangements can affect admissions before any individual routing decision occurs. Entry charges, volume commitments, exclusive access arrangements and group-level business agreements may influence which insurers are feasible partners. Such features require explicit review because they can create systematic omission even when the allocation algorithm itself does not use compensation. The analysis must consider the extent of exclusion, available alternatives, efficiencies, service quality and potential competitive harm. A supplier payment is a reason to investigate incentives, not by itself proof of unlawful conduct.

Quote Request Allocation and Search Frictions

Sequential, parallel and hybrid solicitation

Routing determines the set and timing of actual requests from the eligible panel. Parallel solicitation can allow several insurers to quote within the same time window, which facilitates comparison and limits the risk that an early offer becomes the only consideration. Sequential solicitation may conserve effort by approaching likely suppliers first and expanding search if initial terms are weak. Hybrid systems can request a baseline group in parallel and initiate manual or specialist referral where initial offers fail to satisfy customer needs.

Honka (2014), in research on insurance search costs, analyzes search and switching frictions jointly in US auto insurance. The accessible abstract describes a model of how many firms consumers consider, which firms they search, and which insurer they select. For panel design, the relevant insight is that procurement effort has an economic cost and the observed consideration set is an outcome of search decisions. The cited research concerns consumer search in a particular historical market; it does not estimate the welfare effect of a contemporary broker's routing algorithm.

Sequential search requires a defensible stopping condition. A system might stop when the returned terms satisfy a pre-specified coverage threshold and the cost of further delay becomes disproportionate to the expected improvement. That decision should depend on the insurance requirements and the value of more information. Stopping when a high-commission carrier returns a quote, regardless of price or protection, creates a distinct conflict. A system that stops after a fixed number of offers may also systematically disadvantage risks whose only suitable alternatives require slower underwriting.

Parallel solicitation is not costless. It may burden underwriters with incomplete or speculative applications, expose unnecessary personal data and produce redundant offers from connected sources. High submission volumes can reduce the willingness of insurers to participate or create response delays. Broader search is valuable where it offers a meaningful chance of improved terms or access. The number of solicitations should reflect the marginal value of information, underwriting effort, time constraints, customer requirements and data minimization. The resulting stopping rule must remain open to review.

The sequence of measurable decisions

For each inquiry, let E denote the count of identified eligible alternatives within the panel; R the number of these receiving a genuine request; Q the number returning actionable quotations before the comparison deadline; D the number of actionable quotations made available to the customer; and B the number accepted. For a conventional single-policy purchase, B is zero or one. The counts use a consistent insurer-product unit, common inquiry identifier and specified cutoff. At the pair level, the records preserve requests that received no response, indications, declinations, incomplete responses and final quotes.

Given positive denominators, the aggregate rate D/E decomposes exactly as (R/E) × (Q/R) × (D/Q), provided all counts refer to the same nested cohorts. The identity separates routing intensity, provider response and disclosure. For example, a low displayed quote rate can originate from limited requests, limited insurer appetite after individual review, or withheld or incomparable offers. The arithmetic alone does not infer motive. A controlled exception for a superseded duplicate quote differs from hiding a superior offer. The event log must supply the explanation.

The response measure Q/R must not classify all missing replies as insurer rejection. At a fixed observation deadline, the distribution of unresolved requests is partly a result of the timing of submission. If carrier A is approached on Monday and carrier B immediately before a Friday deadline, the comparison of response rates confounds response behavior with broker scheduling. To assess service latency, measure elapsed time from the individual submission, preserve the deadline, and treat outstanding responses as censored where the statistical method requires it.

A quote request may itself be defective. Missing schedules, inconsistent valuations, unsupported assumptions or incompatible effective dates can make the insurer's response less useful. Different versions of the same request should not be counted as new independent market opportunities. The audit should identify a unique inquiry, the insurer-product pair, the submission version, any material changes and the final offer used in the comparison. Revised quotes supersede earlier ones only within a documented chain.

An illustrative allocation audit

Consider a synthetic portfolio of 200 inquiries, divided equally between groups A and B of 100 each. The two groups are assumed here to have the same reference-panel eligibility counts solely to demonstrate the arithmetic. In real data this assumption would require verification. Across each group there are 400 eligible inquiry-insurer pairs. The following numbers are hypothetical; group names do not designate protected characteristics or actual populations.

Stage Group A Group B
Eligible inquiry-insurer pairs 400 400
Genuine requests sent 320 240
Actionable quotations received 240 180
Actionable quotations shown 216 144

For A, the request rate is 320/400 = 80 percent, response among requests is 240/320 = 75 percent, and disclosure among actionable quotations is 216/240 = 90 percent. The overall displayed-to-eligible-pair rate is 216/400 = 54 percent. The product of the three conditional rates is 0.80 × 0.75 × 0.90 = 0.54.

For B, the request rate is 240/400 = 60 percent, the response among requests is 180/240 = 75 percent, and disclosure among actionable quotations is 144/180 = 80 percent. The displayed rate is 144/400 = 36 percent, equal to 0.60 × 0.75 × 0.80. The group difference in displayed opportunities is 18 percentage points, and the ratio B/A is two-thirds. The equal conditional response rates direct attention to broker-controlled transitions, although different mixes of insurers within the two solicited sets could still matter.

An additive decomposition depends on the order of replacement. Starting at group B's observed rates, substitute A's routing rate while holding B's response and disclosure rates fixed: 0.80 × 0.75 × 0.80 = 0.48. This accounts for 12 percentage points of the 18-point gap in this ordering. Then substitute A's disclosure rate to obtain 0.54, accounting for the remaining six points. If disclosure is replaced first, the contribution of disclosure is 4.5 points and that of routing 13.5 points. Both decompositions are algebraically correct. Neither is a causal estimate; they allocate an observed multiplicative difference under hypothetical replacements.

The example also demonstrates why pair-level rates do not reveal customer-level access. Group A's 216 displayed quotations could be spread across all 100 customers or concentrated among a fraction of them. Group B might have numerous customers with just one offer and a smaller subset with several. A second dataset must report the distribution of distinct actionable alternatives per inquiry, the share obtaining at least one offer, the share obtaining multiple coverage-compatible offers, the no-quote rate and the time to a usable offer. It must include abandoned inquiries.

Hypothetically suppose that an inquiry receives two offers with the same insured limit and equivalent covered perils. Offer X has an annual premium of $900, a deductible of $1,000 and a broker fee of $40; offer Y has an annual premium of $980, a deductible of $500 and a broker fee of $20. Under the deliberately simplified assumption of one qualifying claim with probability 0.10, always in excess of both deductibles, expected annual direct outlay is $940 + $100 = $1,040 for X and $1,000 + $50 = $1,050 for Y. Under these assumptions X has a $10 advantage in expected direct outlay, despite Y providing the lower retention. If claim probability rises to 0.20, the figures become $1,140 and $1,100 respectively, reversing the ordering. This illustration excludes coinsurance, claim distributions, tax and risk aversion. A liquidity-constrained customer may prefer the lower deductible even at the first probability. The example establishes the need for contract comparability and preference information, not a universal pricing rule.

Dynamic allocation and feedback

Historical success rates, insurer response models and broker experience can improve routing. However, observed performance data reflect earlier allocation decisions. An insurer receiving mostly unsuitable submissions may look unresponsive compared with a favored insurer receiving carefully prepared applications. Conversely, a seldom-used insurer may have too little historical data for a reliable score. Adaptive policies can perpetuate these differences because the data used to evaluate a provider are generated by the policy itself.

The solution is not unrestricted random routing. Where all candidate providers are legally and operationally acceptable, limited randomized ordering or supplemental requests can produce information about otherwise underobserved alternatives without withholding essential protection. The study must specify a minimum search standard, maximum delay, confidentiality safeguards and eligibility constraints. The customer should not bear a material loss of service solely to generate research data. Random exploration should complement a professional decision process.

Risk and supply conditions also evolve. A model calibrated before a major weather event or insurer withdrawal may route to markets that have ceased accepting the relevant exposure. Updated appetite information, temporally appropriate model testing and documented overrides are necessary. Historical comparisons should use the information that was available at the time of allocation; applying a later appetite rule retroactively can falsely convert a legitimate original request into an apparent error.

Fair Personal Analysis and Incentive Conflicts

The scope and evidentiary basis of advice

Advice is a reasoned recommendation about a contract that addresses the particular customer's insurance requirements. Its scope matters. The original EU Insurance Distribution Directive (European Parliament and Council, 2016), Article 20, connects insurance distribution with customer demands and needs and provides an additional sufficiently broad market-analysis requirement when the intermediary represents its advice as fair and personal. Article 19 distinguishes the associated disclosures about service scope and remuneration. These provisions establish the relevance of the comparison universe; they do not prescribe a universally optimal count of quotations.

An intermediary must be able to separate the evidence of assessment from evidence of selection. A demands-and-needs record can establish the customer's priorities without showing that compatible alternatives were solicited. A routing log can establish search effort without showing that the returned terms were adequately understood. A recommendation file must connect the two. It should record the evaluated quotes, material coverage differences, reason for recommendation, and relevant restrictions on the search. Where an insurer is unavailable or declines, the record should identify that status accurately rather than count it as a competitor's offer.

The IDD addresses these matters in a wider statutory context. Article 17 articulates the obligation to act in customers' best interests and addresses remuneration, performance assessment and sales targets that conflict with this obligation. The article's concern extends beyond payments to the legal entity. Employee incentives can create the same routing pressures if sales targets disproportionately reward particular products or carriers. In examining conduct, one should inspect the entire remuneration pathway from insurer to intermediary to individual decision maker.

A useful distinction is between undertaking a broad search and providing a neutral recommendation. The broker can search widely and then steer the customer through selective explanations. Alternatively, a broker can make a genuinely reasoned comparison within a narrow, accurately described panel yet offer limited market reach. The scope and merit of the service can be evaluated separately, subject to the applicable legal requirements. A claim of fair and personal analysis imposes different expectations from a transparently limited distribution service.

Compensation and competing incentives

Insurer-paid percentage commissions, client-paid fees, fixed expenses, contingent remuneration, service contracts and volume-based benefits can generate different marginal rewards for an intermediary. A percentage commission increases in absolute value with the premium if the commission rate remains fixed. A volume bonus can create a discontinuity near an agreed target. A profitability-based arrangement may reward submissions that an insurer regards as favorable. A client-paid fee can also distort effort when a fixed payment makes complex inquiries costly to serve. The appropriate question is how the arrangement changes the intermediary's payoff at the point of search and recommendation.

Cummins and Doherty (2006) discuss the possible economic benefits of intermediary compensation arrangements, including incentives that can improve insurer confidence in the risk selection process. Their abstract also reports that commissions can be reflected in premiums. Focht, Richter and Schiller (2013) consider alternative remuneration systems in a theoretical matching setting. These works support a balanced inquiry into incentives, information production and matching quality. Their conditional results cannot be treated as proof that any particular compensation contract benefits its customers.

Empirical evidence of harmful advice appears in a different setting. Anagol, Cole and Sarkar (2017), in field experiments on insurance advice, report that agents in the Indian life insurance market frequently recommended unsuitable high-commission products and describe substitution following product-specific disclosure requirements. The available abstract identifies both compensation incentives and limited knowledge as relevant mechanisms. This evidence establishes the possibility of distorted advice and the limits of narrowly targeted disclosure within the studied population. It does not establish an identical effect size for independent property-casualty brokers in another jurisdiction.

A hypothetical commission comparison makes the conflict concrete. For two otherwise equivalent contracts with premiums of $1,000 and $1,100, commission rates of 10 percent and 15 percent produce intermediary gross commissions of $100 and $165. If the second contract provides no compensating customer benefit, recommending it creates a $100 additional customer premium and a $65 increase in intermediary gross receipts. These figures exclude taxes, costs, and any other payments. Where the second contract has materially superior protection, its higher commission is insufficient evidence of inappropriate advice. The conflict consists in the dependence of intermediary remuneration on the choice, while the relevant conduct question concerns the justification for the selection.

Incentives may also operate at the admission stage. An insurer could offer access to services or enhanced commission conditional on placement volume. A change in the panel then affects all customer inquiries, including those without individualized steering. An audit limited to recommendation scores will miss this mechanism. Similarly, internal service-level targets may push staff toward rapid quoting at the expense of suitable manual markets. Complaint and conversion incentives can produce unintended distortions even when no carrier-specific payment exists.

Genuine offers and historical enforcement evidence

The historical New York insurance brokerage investigations illustrate the seriousness of the integrity problem. The 2004 complaint against Marsh, filed by the New York Attorney General and reproduced in an SEC filing, alleged compensation-related steering and the solicitation of noncompetitive bids giving the appearance of competition. It is a pleading containing allegations, not a judgment establishing every alleged fact. The allegations identify specific conduct that should be detectable in a properly maintained audit trail: preferred-market directions, apparently competing but non-genuine quotations and restrictions on solicitation.

Marsh & McLennan Companies' 2005 quarterly securities filing describes the settlement and the resulting reforms, including a customer compensation fund for which the company recorded an $850 million charge and arrangements for disclosing quotations and compensation. These were historical settlement terms reported by the company. They must not be generalized into current statutory requirements for all brokers. They demonstrate that a process can create a false impression of competitive search even when a customer receives several written prices.

An authentic quote should be traceable to an independently authorized insurer or underwriting market, with the risk submission, terms, issue time, validity period and material revisions recorded. An indication of interest is different from an actionable quotation. A knowingly noncompetitive courtesy response, fabricated quotation or unapproved representation of insurer terms undermines evidence of competition. When the broker receives only one genuine offer, transparent disclosure of that fact preserves the distinction between limited availability and artificial comparison.

The UK's 2019 wholesale broker market study supplies important countervailing context. The FCA reported that it found insufficient evidence of significant competitive harm warranting intrusive remedies, while identifying conflicts, disclosures and certain broker-insurer contracts requiring further attention. Its public summary concerns the investigated wholesale market and period. The existence of the earlier New York allegations does not establish market-wide harm in London; nor does the FCA's conclusion eliminate the need for quote integrity controls in an individual intermediary. Scientific evaluation must retain both the mechanisms of possible harm and the actual limits of the evidence.

Disclosure, avoidance and comparison

Disclosure makes incentives visible, but it does not necessarily change them. A customer may lack the knowledge to judge whether a bonus materially affects the recommendation. A disclosed conflict may still impair a decision if alternatives were excluded before the customer saw the terms. Internal management of conflicts should therefore address panel admission, routing, candidate evaluation and communication in addition to compensation statements.

Possible measures include separating authority for insurer commercial agreements from authority over recommendation criteria, prohibiting false representations of quote provenance, examining overrides for compensation dependence, requiring approval for material remuneration changes, and testing recommended contracts against coverage-compatible alternatives. A compensation-neutral reranking of already returned quotes is one diagnostic. It can reveal whether a recommendation depends on remuneration, but it cannot discover omitted insurer requests without additional data.

The insurer also has responsibilities within its own role. It should be able to substantiate the offers communicated in its name and detect unusual referral patterns or repeated requests for non-genuine comparative terms. A conduct review can examine whether commercial payments to intermediaries correspond to genuine services and whether distribution arrangements improperly restrict competition. This inquiry remains separate from the insurer's ability to decline risks or determine actuarially justified terms.

Algorithmic and Human Steering Tests

Decisions, records and outcomes

Algorithmic routing and human selection have a common evidentiary structure. Both choose where to send a request using information available at a particular time. Human judgment may be expressed through a referral note; automated judgment may be represented by rules, model scores, optimization criteria and overrides. The relevant question is whether the reason and consequence of the allocation are reconstructable. The fact that an algorithm produced the decision does not determine its fairness.

The minimum audit dataset includes inquiry identity, customer and product segment, jurisdiction, requested coverage, relevant risk attributes, insurer and group identity, panel membership period, eligibility flags and their sources, submission timing, request completeness, response status, standardized quote fields, disclosure status, recommendation and eventual purchase outcome. It also includes the routing-policy version, any override, compensation metadata with effective dates, and relevant permissions governing the use of data. Record the entity responsible for every material transition. Preserve contemporaneous snapshots rather than applying today's panel to yesterday's inquiry.

Where group fairness is assessed, the analyst must define both the group characteristics and the relevant comparison population. A legitimate difference in risk may affect eligibility. A variable associated with a protected characteristic can be a proxy, and its apparent predictive usefulness does not establish that it is lawful or appropriate for the intended purpose. Conversely, not observing protected characteristics limits some tests; it does not demonstrate that disparities are absent. The lawful availability and use of group information should be settled before collection and analysis.

A simple descriptive indicator is the proportion of eligible pairs routed within each insurer and customer segment. For provider j, the numerator is the number of eligible inquiries actually sent to j, and the denominator is the number eligible for j under a contemporaneous rule. Compare providers only after accounting for product scope, operating capacity, channel, price or service information legitimately available prior to the request, and customer requirements. Where insurer-specific eligibility is unknown, report the resulting uncertainty rather than substituting eventual acceptance for prior eligibility.

Conditional comparisons and causal limitations

A matched audit constructs groups of inquiries similar in relevant observed characteristics at the point of routing. Strata can be defined using product, coverage requirements, location where lawfully relevant, exposure indicators, application completeness, broker branch, calendar period and the available panel. Within such strata, differences in quote allocation can be calculated with uncertainty intervals. Exact matching is transparent but may discard many unusual risks; coarser matching improves sample size at the cost of residual heterogeneity. The number and characteristics of unmatched observations belong in the report.

Regression can supplement matching. A binary outcome at the inquiry-insurer level indicates whether a request was sent. An estimated model can include insurer, broker and period effects and pre-decision risk covariates. An association with a remuneration change is informative only under assumptions about the comparability of those observations and the absence of unmeasured shocks. A new commission agreement may coincide with an insurer's new product, revised appetite, technical integration or expedited service. The estimated coefficient does not isolate the effect of remuneration unless the design credibly separates these events.

Temporal designs can examine behavior near a compensation-policy change. A difference-in-differences analysis would require a suitable comparison and a plausible counterfactual evolution in the absence of the change. Inspect pre-event trends, changes in cohort composition, contemporaneous product revisions and anticipatory behavior. A volume threshold may produce incentives to accelerate submissions near the end of a period, but a threshold can coincide with seasonality or sales-cycle changes. Any threshold analysis must examine the possibility of strategic manipulation of the running variable.

A further source of bias is conditioning on returned quotations. If the routing decision determines which insurer has a chance to respond, analyses of prices among received quotes implicitly select on prior search. The lowest premium in the observed set is a lower order statistic whose distribution depends on the number and characteristics of offers sampled. Comparing two brokers' lowest quotes without normalizing the underlying risk and coverage set, and without recognizing the missing alternatives, mixes price, search effort and selection.

Suppose a hypothetical audit observes an allocation rate of 70 percent to a high-remuneration insurer and 50 percent to a lower-remuneration insurer among superficially similar inquiries. The 20 percentage point difference is a descriptive contrast. If the higher-remuneration insurer is also the only provider offering a necessary extension for a fraction of the inquiries, the comparison is confounded. If a coverage-matched subset shows a persistent difference after excluding that extension, the case for further investigation strengthens. Direct examination of policy rules, commercial agreements, underwriter availability and contemporaneous records remains necessary. Statistical suspicion is not a finding of individual misconduct.

Inference should account for dependence. Several insurer observations share the same customer, staff member, branch or time-specific shock. Standard errors treating all pairs as independent may understate uncertainty. Cluster or resample at suitable decision-making units, taking account of the sampling design and number of clusters. When many insurers, risk groups or outcomes are tested, predefine primary endpoints, report multiple-comparison treatment and reserve confirmatory data for material findings where feasible.

Field audits, mystery shopping and controlled comparisons

A complementary method is to submit matched hypothetical insurance profiles through legally and ethically permitted channels. Standardized scenarios can vary one pre-specified feature while holding coverage objectives, effective period, risk facts and information completeness fixed. The audit can examine the number of offers, time to first actionable quote, treatment of referrals, recommendation rationale, total disclosed price and visibility of limitations. It should use randomized order and avoid transmitting fabricated material information in a real binding application. Test arrangements should prevent unintended contracts, minimize unnecessary underwriting burden and obtain required institutional authorization.

The method has limits. A shopper generally observes the communicated result but may not observe which insurer requests were generated. A low quote count can arise from backend allocation or actual underwriting decline. The design is stronger if mystery-shopping results can be reconciled with authorized transaction logs. Similarly, shopper identities and geography can be correlated with legally relevant risk factors, making isolated comparisons ambiguous. A carefully designed scenario should specify what is held constant and what necessarily changes.

EIOPA's 2025 coordinated mystery shopping results concern insurance-based investment products, and report a weak relationship between process thoroughness and how well offered products aligned with shopper profiles. EIOPA's second mystery shopping exercise, announced April 2026, concerns online non-life sales with results expected in 2027. The first supplies a precedent for examining communicated outcomes separately from formal process completion; the second establishes a planned investigation, not observed non-life findings as of this research cutoff.

An internal paired test can use otherwise identical inquiry records in a nonproduction environment while changing a routing parameter. Replaying these records against the same versioned appetite and scoring rules isolates mechanical dependence on that parameter. The test can identify direct feature use, hidden eligibility constraints or differing treatment of tied scores. It cannot establish the effect on real customers without evidence that the test distribution represents actual inquiries. The environment must use nonbinding requests and avoid disclosing protected or unnecessary personal information.

Data protection and accountability

Privacy and fairness evaluation must be reconciled. The General Data Protection Regulation (European Parliament and Council, 2016b), where applicable, supplies rules on lawful processing, minimization, special-category information and automated decisions. Article 22 concerns decisions made solely by automated processing with legal or comparably significant effects, subject to the provision's exceptions and safeguards. A routine internal ranking is not automatically such a decision; the actual effect and role of human involvement must be established in context.

Sensitive group data should not be collected simply because a fairness dashboard is planned. The investigator should identify the lawful basis, any applicable additional conditions, data minimization approach, access restrictions, retention period, and risk assessment requirements. A secure authorized audit dataset can be separated from operational routing data. Pseudonymized personal data may remain subject to data-protection rules. Aggregate publication should avoid re-identification, especially in small or rare risk classes.

A human override is valuable where it improves matching or accommodates a legitimate exceptional need. It can also be a pathway for preference or discrimination. Audit versioned overrides alongside the base algorithm, including reason, approver, outcome and timing. A nominal human review that routinely accepts automated output does not establish meaningful scrutiny. Governance should examine the practical authority of reviewers, access to relevant information and whether they act independently of incentives that generated the initial recommendation.

Regulatory Comparisons and Consumer Outcomes

European Union

The EU framework establishes a useful distinction among customer-interest conduct, intermediary service disclosures, demands and needs, and fair personal analysis. Articles 17, 19 and 20 of Directive (EU) 2016/97 are central to studying panel design. Article 20(3) concerns the scope of analysis when that particular form of advice is represented. The size and features of the relevant market and the customer's needs matter to the sufficiency inquiry; the original directive's recital 47 explicitly draws attention to these factors. Numerical parity in requests or a fixed panel-size threshold is not stated in those provisions. EIOPA's rulebook reproduces the customer-interest and remuneration principle, intermediary disclosure requirements, and fair and personal analysis requirement (EIOPA, 2024a–c). These provisions were cross-checked against that reproduction. The information exemptions and flexibility clause (EIOPA, 2024d), Article 22, permits omission of the information in Articles 18–20 for insurance of large risks and allows stricter national information provisions; it does not itself exempt Article 17. The commercial application of the research analysis therefore must be distinguished from the legal applicability of specific disclosure requirements.

The directive must be understood through its legislative form and national implementation. It sets a harmonized framework with room for national rules; exact obligations depend on activity, customer, product, exemptions and local law. This monograph uses the original directive text for the identified provisions, not an assertion of comprehensive verification of every subsequent amendment or national measure. The regulatory implications are limited to those provisions and the documented supervisory context.

EIOPA's 2026 third IDD application report announcement describes continued market-structure changes, uneven quality of advice and selling methods, persistent inducement concerns in some markets and the evolving role of digital distribution. It is an official summary of the report; the full report and all underlying national data were not comprehensively reviewed here. The summary establishes that formal regulatory implementation and favorable individual outcomes remain distinguishable. It does not provide a transaction-level measure of broker panel completeness.

United Kingdom

UK insurance conduct regulation offers a direct link between panel governance and disclosed service scope. ICOBS 4.1 distinguishes personal recommendation based on fair and personal analysis, exclusive distribution arrangements and other restricted forms of service. Its panel guidance addresses ongoing adequacy and selection criteria. The FCA Handbook page examined incorporates updates identified as of June 2026. The chapter should be read together with applicable advised-sales rules, product governance and other requirements in a specific case.

A fair-analysis process needs evidence that the intermediary considered relevant alternatives in the appropriate market segment and updated its selection where better contracts became available. The standard is sensitive to the product and the service represented. A small specialist panel may be adequate for a well-defined class; a much larger general panel can be inadequate where the broker systematically ignores insurers suitable for a particular customer group.

The FCA's historical 2014 comparison website thematic review found weaknesses in the information supplied to customers, including the risk of excessive focus on the headline premium relative to coverage and exclusions. The FCA labels this review historical. The findings are therefore used as evidence of a past observed comparison problem rather than current market prevalence. Their applicability to broker quotation is limited to the shared problem of communicating comparable insurance terms.

The 2019 wholesale market study findings provide a distinct competition assessment, not a determination of every retail broker's responsibilities. Comparative analysis should distinguish wholesale placement structure from retail panel breadth. This permits a careful interpretation of evidence of intermediary concentration: market shares, commercial terms, barriers to entry, insurers' access to business and actual customer outcomes must be evaluated jointly.

United States and the New York example

US insurance distribution is regulated substantially through state law. An individual state's producer duties, compensation disclosure rules and available remedies should be identified before assessing a particular transaction. The 2004 New York complaint and subsequent settlement are historical records rather than an all-state rule. New York's Department of Financial Services Circular Letter No. 18 (2010), discussing Regulation 194, distinguishes disclosures linked to the sale of insurance from the use of an application merely to obtain multiple quotes; it also addresses disclosures upon request and other implementation matters.

This distinction matters to the quotation stage. A broker's initial solicitation may precede certain mandatory sale-related disclosures. It follows analytically that a conduct audit requires access to internal records about compensation and allocation even when a particular disclosure obligation is activated only later. The letter does not establish a general US rule requiring or forbidding particular panel sizes, nor does it resolve duties arising under other law. Its timing distinction is useful when designing a transaction history.

The historical record supports scrutiny of fake bids and preferential access independently of the ultimate premium paid. A manipulated comparison can impair the customer's ability to exercise choice even if a cheaper quote cannot be independently reconstructed. Competition enforcement, insurance regulation and private legal duties have different elements of proof and remedial purposes; the evidence of a quotation irregularity must be evaluated against the applicable legal framework.

Ontario and supervisory principles

The Financial Services Regulatory Authority of Ontario (FSRA) adopted a supervisory approach effective January 1, 2021, applying the joint Canadian CCIR/CISRO fair-treatment guidance within its stated scope. Its Fair Treatment of Customers page describes the lifecycle orientation of supervision and identifies areas such as governance, incentives, remuneration and point-of-sale information. FSRA expressly distinguishes its approach guidance from an independent source of binding compliance obligations. Its listed covered entities include insurers and specified agency and adjusting entities; one should not assume that all Ontario broker regulation falls within this particular FSRA instrument.

The relevance to panel science lies in the relationship between organizational arrangements and customer outcomes. Quotation should be evaluated as a stage of the insurance lifecycle. An apparently attractive offer that is poorly aligned with the customer's risk can create downstream problems at claim time. Supervision of incentives and governance can therefore complement evaluation of the actual contracts obtained. The approach illustrates the portability of a lifecycle perspective without establishing identical duties across Canadian provinces.

Comparative interpretation

These jurisdictions use distinct legal instruments and supervisory arrangements. The EU original directive supplies obligations concerning service representation, demands and needs, and conduct; the UK Handbook elaborates direct guidance on panels; New York's historical and regulatory materials emphasize the integrity of brokerage and disclosure of compensation within a specified transaction context; the Ontario instrument describes lifecycle-oriented supervision for particular regulated entities. Their convergence concerns transparency of service, management of conflicts and customer interests. Differences in legal status, applicability and remedy cannot be erased through an apparently uniform metric.

Several practical implications follow. A provider's commercial suitability for a panel is compatible with the need to avoid distortions in recommendations. Adequate disclosure of a limited panel helps a customer understand the service, but cannot by itself cure a failure to meet a legally applicable fair-analysis obligation. A conflict may be disclosed yet require additional management. Underwriting differences can justify unequal routing, but the reasons must correspond to legitimate product and risk criteria rather than retrospective explanations based on which policy was ultimately bought.

Global comparison also requires a common scientific vocabulary independent of local terminology. "Agent," "broker," "producer," "intermediary" and "distributor" do not denote identical legal relationships across markets. Classify the activity performed, contracting parties, authorization, remuneration pathway, discretion over routing and responsibility for advice. Then attach the jurisdiction-specific legal provisions. This approach supports comparison of equivalent functions without asserting that their legal labels carry the same implications.

Customer outcomes and the value of the choice set

A customer outcome should be assessed at multiple stages: obtaining access to at least one relevant offer, having meaningful alternatives, comprehension of material terms, total cost, coverage adequacy, satisfaction with the service and later outcomes where observable. Purchase conversion is insufficient. High conversion can reflect customer satisfaction, excellent matching or the absence of a realistic alternative. Low conversion can reflect expensive terms, reasonable comparison-shopping or unmet needs. A fair outcome assessment should preserve the different interpretations.

The useful price variable is total payable premium and relevant fees for an explicitly specified contract. The relevant coverage variables include limits, deductibles, exclusions, insured activities and property, conditions and available extensions. Service quality may matter substantially where a customer faces complexity at claims time. A risk-adjusted premium comparison is possible only with suitable exposure and contract data. It should not classify two policies with different protection as economically identical.

A customer with limited time or financial resources may experience greater harm from the same search barrier than another customer. A comprehensive evaluation therefore reports outcome distributions rather than only average prices. Identify tails of waiting time, no-quote outcomes and large coverage shortfalls within defined customer segments. Examine whether referral and escalation mechanisms assist those facing unusual underwriting restrictions or difficulties completing applications.

The Competition and Markets Authority's digital comparison tools study illustrates the regulatory interest in comparison services as market institutions. Its 2017 case record documents a completed market study and supporting consumer and competition research. The study's cross-sector scope should not be mistaken for evidence about every insurance broker. Its methodological relevance is the need to examine both the customer-facing service and the relationships among suppliers and the intermediary through which comparison is provided.

Scientific Evaluation and Operational Controls

A reproducible evaluation protocol

A defensible evaluation begins with a written statement of research purpose. Is the concern reduced customer access, market representation, remuneration-induced steering, genuine quote integrity, or disparities across customer groups? These questions overlap but require different outcomes and comparators. Specify the product, territory, date range, role of the broker, promised scope of service and actual legal obligations. Define the insurer-product unit and corporate group mapping, along with rules for counting revised quotes, multiple coverages and referrals.

Next reconstruct the reference market, accessible panel and individual eligibility records. Document which data come from licensing or product information, underwriting agreements, versioned appetite rules or insurer responses. Assign an epistemic status to each eligibility determination: confirmed eligible, likely eligible, unknown, or excluded for a documented reason. Avoid silently converting unknown pairs into ineligible pairs. Report baseline counts and the number of observations for which the reference universe could not be reconstructed.

The primary outcome table should display denominators and time windows. Useful rows include all inquiries, completed applications, inquiries with at least one eligible panel member, requests, actionable quotes, coverage-compatible quotes, disclosed quotes, accepted policies, and unresolved or abandoned inquiries. Include the distribution of unique insurer groups per inquiry. Pair-level opportunity rates and customer-level access measures are both required when drawing conclusions about breadth and fairness. Their difference is substantive, not merely a formatting concern.

A sensitivity analysis should vary plausible eligibility definitions, inclusion of manual markets, treatment of timeout responses, quote comparison deadline, risk covariates and the grouping of related insurers. If a disparity exists only under an unsupported assumption that every unobserved insurer was eligible, report the fragility. If the result persists across independent plausible definitions, targeted investigation is warranted. Where missing data are concentrated among particular customer groups, analysis limited to complete cases may be especially misleading.

A quantitative evaluation should specify its statistical uncertainty and robustness plan before examining the results. Use valid confidence intervals for the actual sampling and dependence structure. Distinguish descriptive estimates from causal estimands, and record hypotheses that arose after seeing the data. The scientific report must identify what conclusion would be justified by each result, including null results under limited sample size and measurement quality. No threshold used for an internal dashboard should be presented as a universal legal test.

Missing data and partial identification

Absent historical eligibility evidence, the universe of omitted alternatives cannot be exactly recovered. Suppose a synthetic audit identifies 80 confirmed eligible insurer-inquiry pairs with 60 routed requests, and 20 additional pairs with unknown eligibility, none of which were routed. If the unknown pairs were all ineligible, the confirmed-and-possible eligible routing rate would be 60/80 = 75 percent; if all were eligible, the rate would be 60/100 = 60 percent. Under the stated assumptions the rate lies between 60 and 75 percent. This is a bound on a descriptive measure, not an estimate of which unknown pairs truly were eligible.

If some unknown pairs were routed, the bounds would require a different numerator treatment. If records of omitted insurers are themselves incomplete, the possible eligible universe could exceed the 100 pairs in the example. The analysis must therefore identify which uncertainties are bounded by recorded data and which are not. An apparently precise fairness result based on treating missing information as exclusion can systematically overstate panel performance.

A similar problem occurs when quote disclosure records are absent. A quote not found in the customer interface could have been communicated by telephone; a quote in an internal database could have been communicated only after expiry. Reconstruct the chain through authorized records of communication, document version and timestamp, while protecting customer privacy. Where the reconstruction remains incomplete, present the observed disclosure evidence and its limitations rather than presume that an unlogged action occurred.

Governance and independent assurance

Responsibility for panel approval, compensation agreements, routing design, customer advice, data protection and independent testing should be assigned clearly. Where responsibilities overlap, material conflicts need escalation. Governance records should preserve decision criteria and the reasons for departures from them. A periodic review should identify ineffective panel members, missing specialist markets, changes in contractual terms, unequal access patterns and repeated instances of insufficient comparison.

A quote provenance record can be tested by reconciling sampled broker records against authorized insurer confirmations. Check whether the original risk description and key terms correspond, whether quotes were valid when displayed and whether material exclusions were presented. Examine instances in which an offer was received but omitted from the customer comparison. Possible explanations include duplication, incompatibility with the requested coverage, supersession, expiration or a recorded customer instruction. Each reason should be supported by the transaction record.

Changes to a routing rule require a controlled review. Document the new and previous rules, intended objective, affected product and risk classes, pre-release tests, anticipated adverse effects, approval authority and rollback criteria. Test scenarios should include unusual but legitimately insurable risks, ties, insurers with temporarily missing responses and cases requiring manual referral. Retain the ability to reproduce routing from the historical inputs and rule version; evaluate changes in outcome after implementation without using the post-change outcome to rewrite the pre-change decision history.

Independent governance is especially important around compensation changes. A reviewer can compare the effective dates of insurer contracts with shifts in eligibility judgments, request volume, response timing, quote disclosure and recommendations. Investigate unusual patterns at reporting deadlines when contingent rewards become relevant. Examine whether the changes coincide with genuine improvements in product or insurer service. The purpose is to identify cases requiring evidentiary resolution, rather than equate all allocation differences with conflicts.

Controls should serve the scientific purpose of reliable evaluation and the institutional purpose of adequate insurance access. Additional forms are useful only if they preserve meaningful facts. A checklist that records a completed needs analysis while ignoring the relevant search universe cannot answer the central research question. Equally, a comprehensive event log without review responsibilities may produce data without correcting poor practice.

Remediation and research boundaries

When deficiencies are found, remediation should address the stage at which they arose. If a panel omits important carriers, examine admission and referral arrangements. If eligible opportunities are unequally routed without justification, revise the decision rule and assess affected inquiries. If responses are missing because of timing, revise service deadlines and monitoring. If valid offers are suppressed, review disclosure and recommendation practices, identify affected customers and determine any corrective communication or remedies under applicable law. If supplied information is inconsistent, correct the application and data-quality process.

The effects of remediation require measurement. A wider panel may generate additional quotes without improving coverage-compatible alternatives. A refreshed routing rule may improve opportunity rates but introduce slower service. Reducing a remuneration conflict may change broker effort or supplier participation. Compare a pre-specified set of access, suitability and service measures, considering changes in market conditions and customer composition. Do not report success solely through the number of procedures adopted.

The empirical research agenda is correspondingly specific. Independent transaction-level datasets recording unsent eligible alternatives, genuine requests, actual responses, compensation conditions and customer outcomes would permit stronger estimates of the contribution of panel governance to insurance access. Prospective designs comparing lawful routing alternatives could identify local effects on search effort and observed choice quality. Longitudinal records linking contract selection with claim outcomes would help evaluate suitability, subject to the selection and confidentiality constraints inherent in such studies. These are research opportunities, not results established here.

In this monograph, the hypothetical audit, price comparison and eligibility bounds were constructed to make measurement and inference requirements explicit. The common opportunity-chain representation organizes established institutional concepts and elementary arithmetic. It is an analytical synthesis for the dossier's subject, not a new theory or a calibrated actuarial model. The regulatory comparisons are selective, and some source access was limited to official summaries or academic abstracts. The conclusion is grounded in the scope of the sources and the explicitly stated illustrative assumptions.

Conclusion

The insurance quotation panel determines the opportunities through which a customer's risk can become a contract with an insurer. Panel governance establishes the reachable market; allocation determines which members actually see a request; underwriting contributes responses; disclosure establishes the visible set; recommendation interprets the contractual alternatives in relation to the customer's needs. The independence of these stages is indispensable to the evaluation of intermediary conduct.

A fair quotation process is a reasoned and verifiable search among relevant alternatives within the legally applicable scope of service. It can accommodate specialization, underwriting constraints, legitimate differences in insurer performance, processing costs and justified exclusions. Its adequacy depends on the contemporaneous market, the actual customer need, the authenticity and comparability of offers and the transparency of the service's limits. A nominally large panel is insufficient evidence of these qualities.

The remuneration literature and enforcement history demonstrate why incentive conflicts require direct investigation while differences in legal instruments and empirical settings limit generalized conclusions. Intermediary compensation can support information production and matching; it can also distort admission, solicitation and recommendation. A scientific assessment must examine the exact mechanism and customer consequences rather than infer appropriate or inappropriate conduct solely from the type of payment.

The numerical and methodological analysis establishes three practical conclusions. First, quote opportunity, carrier response and customer disclosure have different denominators, and relying on bound policies or headline prices loses information essential to fair-access evaluation. Second, conditional comparisons can identify suspect allocation patterns but require credible eligibility, risk and time controls before causal interpretation. Third, contractual protection is multidimensional: price, indemnity conditions, deductibles, service and customer requirements must be reconciled before ranking offers.

Transparent reference-market definitions, preserved transaction evidence, documented exceptions, independent checks and appropriate escalation provide the foundations for accountable panel management. Where the underlying opportunity set is incompletely known, uncertainty should appear explicitly in the assessment. This makes governance open to improvement and evaluation while preserving the legitimate functions of insurance underwriting and brokerage. The resulting scientific criterion is the demonstrated quality of the customer's opportunity to obtain suitable insurance under the service offered, supported by a reconstructable and credible quotation process.

References

  • Anagol, S., Cole, S., & Sarkar, S. (2017). Understanding the advice of commissions-motivated agents: Evidence from the Indian life insurance market. The Review of Economics and Statistics, 99(1), 1–15. DOI: 10.1162/REST_a_00625. Bibliographic record and abstract.

  • Competition and Markets Authority. (2017). Digital comparison tools market study. Final report and case record, September 26, 2017. Official study record.

  • Cummins, J. D., & Doherty, N. A. (2006). The economics of insurance intermediaries. Journal of Risk and Insurance, 73(3), 359–396. DOI: 10.1111/j.1539-6975.2006.00180.x. Bibliographic record and abstract.

  • European Insurance and Occupational Pensions Authority. (2024a). General principle (Article 17). Single Rulebook, Directive (EU) 2016/97. Official rulebook text.

  • European Insurance and Occupational Pensions Authority. (2024b). Conflicts of interest and transparency (Article 19). Single Rulebook, Directive (EU) 2016/97. Official rulebook text.

  • European Insurance and Occupational Pensions Authority. (2024c). Advice, and standards for sales where no advice is given (Article 20). Single Rulebook, Directive (EU) 2016/97. Official rulebook text.

  • European Insurance and Occupational Pensions Authority. (2024d). Information exemptions and flexibility clause (Article 22). Single Rulebook, Directive (EU) 2016/97. Official rulebook text.

  • European Insurance and Occupational Pensions Authority. (2025, June 17). EIOPA publishes the results of the first coordinated mystery shopping exercise in the EU's insurance sector. Official results announcement.

  • European Insurance and Occupational Pensions Authority. (2026a, March 30). EIOPA publishes third Report on the application of the Insurance Distribution Directive. Official report announcement.

  • European Insurance and Occupational Pensions Authority. (2026b). Structure of the EU insurance distribution market. Third IDD application report survey overview. Official market data overview.

  • European Insurance and Occupational Pensions Authority. (2026c, April 27). EIOPA to undertake second coordinated mystery shopping exercise across several EU Member States. Official exercise announcement.

  • European Parliament and Council of the European Union. (2016a). Directive (EU) 2016/97 of 20 January 2016 on insurance distribution (recast). Official Journal of the European Union, L 26, February 2, 2016, 19–59. Articles 17, 19, 20, 22; recital 47. Official original text.

  • European Parliament and Council of the European Union. (2016b). Regulation (EU) 2016/679 of 27 April 2016 (General Data Protection Regulation). Official Journal of the European Union, L 119, May 4, 2016, 1–88. Articles 5, 6, 9, 22 and 35. Official bilingual text.

  • Financial Conduct Authority. (2014). Price comparison websites in the general insurance sector. Thematic Review TR14/11, July 15, 2014; historical notice updated August 29, 2025. Official review summary.

  • Financial Conduct Authority. (2019). Wholesale Insurance Broker Market Study. MS17/2, final report record, February 20, 2019. Official study summary.

  • Financial Conduct Authority. (2026). Insurance Conduct of Business Sourcebook, ICOBS 4.1: General requirements for insurance intermediaries and insurers. Handbook page updated June 26, 2026; especially ICOBS 4.1.6R–4.1.8G. Official Handbook text.

  • Financial Services Regulatory Authority of Ontario. (2021). Fair Treatment of Customers in Insurance. Approach Guidance GR0008APP, effective January 1, 2021. Official supervisory approach.

  • Focht, U., Richter, A., & Schiller, J. (2013). Intermediation and (mis-)matching in insurance markets—Who should pay the insurance broker? Journal of Risk and Insurance, 80(2), 329–350. DOI: 10.1111/j.1539-6975.2012.01475.x (online 2012). University repository abstract.

  • Honka, E. (2014). Quantifying search and switching costs in the US auto insurance industry. RAND Journal of Economics, 45(4), 847–884. DOI: 10.1111/1756-2171.12073. Bibliographic record and abstract.

  • Marsh & McLennan Companies, Inc. (2005). Form 10-Q for the quarterly period ended September 30, 2005. SEC EDGAR, discussion of New York Attorney General settlement, pp. 28–29. Company securities filing.

  • New York State Department of Insurance. (2010). Insurance Circular Letter No. 18: Implementation of and compliance with 11 NYCRR 30 (Regulation 194—Producer Compensation Transparency). Official regulatory circular.

  • People of the State of New York v. Marsh & McLennan Companies, Inc., and Marsh Inc. (2004). Complaint, Supreme Court of the State of New York, October 14, 2004. Reproduced in SEC EDGAR. Original complaint exhibit.